SYRE Expands SPY003 License Agreement with Paragon, Broadens Field to All Therapeutic Uses with Dosing Restrictions
Spyre Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $73.50
0.0% in 1h after detection
Post-detection moves
1h
0.0%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS